Cargando…
Immunological Derangement in Hypocellular Myelodysplastic Syndromes
Hypocellular or hypoplastic myelodysplastic syndromes (HMDS) are a distinct subgroup accounting for 10–15% of all MDS patients, that are characterized by the presence of bone marrow (BM) hypocellularity, various degree of dysmyelopoiesis and sometimes abnormal karyotype. Laboratory and clinical evid...
Autores principales: | Serio, B, Risitano, AM, Giudice, V, Montuori, N, Selleri, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Salerno
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000461/ https://www.ncbi.nlm.nih.gov/pubmed/24778996 |
Ejemplares similares
-
Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience
por: Calabretto, Giulia, et al.
Publicado: (2022) -
Cytogenetic as an Important Tool for Diagnosis and Prognosis for Patients with Hypocellular Primary Myelodysplastic Syndrome
por: Corrêa de Souza, Daiane, et al.
Publicado: (2014) -
Eight-ball hyphema after laser iridotomy in a patient with undiagnosed hypocellular myelodysplastic syndrome
por: Arunmongkol, Sira, et al.
Publicado: (2018) -
The CSN5/HSF/SPI1/PU.1 Axis Regulates Cell Proliferation in Hypocellular Myelodysplastic Syndrome Patients
por: Yu, Zheng-Ping, et al.
Publicado: (2023) -
LIG4 Syndrome Associated with Hypocellular Myeloid Dysplasia
por: Tamura, Shinobu, et al.
Publicado: (2018)